Masonic Cancer Center’s Chen and Tocagen Inc. announce ‘impressive’ results.
Apollo Endosurgery is touting an alternative to unpopular bariatric procedures.
The company is awaiting clearance to conduct human trials from the FDA. Once approved, MicroOptix will receive additional funds from an institutional source.
The Intellis platform is now available to hospitals and health care practitioners in the U.S. and Europe.
This is the medtech company’s eighth fundraising round since 2010.
Results in Europe, Japan offset “slowness” in U.S.
The medtech company’s new name is borrowed from a company it purchased earlier in the month.
Prior to its October fundraising round, EnteroMedics had raised over $91 million in seven rounds.
Meanwhile, a spokesman for the medical device maker said its operations in northern California appear to be standing yet inaccessible as wildfires rage on.